DURECT Corp (DRRX) Reports Pfizer (PFE) to Cease REMOXY Development, Commercialization; Updates on POSIDUR
Tweet Send to a Friend
DURECT Corp (Nasdaq: DRRX) reports that Pfizer Inc. (NYSE: PFE) announced that it has notified Pain Therapeutics, Inc. (Nasdaq: PTIE) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE